Home
>
US Stocks
>
Impel NeuroPharma Inc.
Impel NeuroPharma Inc.
IMPL

Impel NeuroPharma Inc.

$9.945.42%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
10.15
Today Low/High
9.75 / 10.38
52 Week Low/High
$6.9 / $34.75
Market Cap
$205.05M

Company Details

Impel NeuroPharma, Inc. is a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for people suffering from diseases with high unmet needs, with an initial focus on diseases of the CNS. The Company’s strategy is to rapidly advance its product candidate pipeline that pairs its proprietary Precision Olfactory Delivery (POD®) system with well-established therapeutics, including TRUDHESA™ for the acute treatment of migraine, INP105 for the acute treatment of agitation and aggression in patients with autism, and INP107 for OFF episodes in Parkinson’s disease.
Organisation
Impel NeuroPharma Inc.
Headquaters
Seattle, Washington, US
Employees
59
CEO
Michael Hite

Discover more

Frequently Asked Questions

What is Impel NeuroPharma Inc. share price today

Can Indians buy Impel NeuroPharma Inc. shares?

How can I buy Impel NeuroPharma Inc. shares from India?

Can Fractional shares of Impel NeuroPharma Inc. be purchased?

What are the documents required to start investing in Impel NeuroPharma Inc. stocks?

We are a SEBI registered investement advisor